Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Pioglitazone (15mg) + Metformin (500mg)
Therapeutic Category
Antidiabetic, Cardiology, Cardiovascular, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*15
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Piobot M Tablet combines Pioglitazone (15mg) and Metformin (500mg) — two well-established oral antidiabetic agents that work synergistically to improve glycemic control in type 2 diabetes mellitus.
Metformin decreases hepatic glucose production and enhances peripheral insulin sensitivity.
Pioglitazone further improves cellular response to insulin and optimizes lipid metabolism.
Together, they help maintain long-term blood-sugar control, prevent diabetes-related complications, and support better cardiovascular outcomes.
Piobot M Tablet belongs to the antidiabetic and endocrinology segment, ideal for patients needing combination therapy. It’s a highly demanded formulation for PCD pharma franchise distribution, third-party manufacturing, and export markets, offering consistent therapeutic outcomes and market potential in India’s rapidly growing diabetes care sector.
Common side effects may include mild weight gain, swelling, headache, and fatigue. In rare cases, it can cause fluid retention, heart failure, or liver-related issues. Patients should report any unusual symptoms like shortness of breath, sudden weight gain, or jaundice to their healthcare provider.
Piobot 7.5 Tablet is indicated for the management of type 2 diabetes mellitus, particularly in adults whose blood sugar levels are inadequately controlled through diet and exercise alone. It may be used alone or in combination with other oral antidiabetic agents to improve glycemic control.
Take Piobot 7.5 Tablet exactly as prescribed, with or without food, at a consistent time each day. Regular monitoring of blood glucose, liver function, and weight is important during therapy. Use with caution if you have a history of heart disease, liver problems, or bladder cancer.
Store Piobot 30 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep the medication out of reach of children.
Composition : L-Arginine (3gm) + Proanthocyanidin (75mg) sachet
Composition : Carvedilol 12.5 tablet
Composition : Carvedilol CR 10mg Tablet
Composition : Carvedilol CR 20mg Tablet
Composition : Clopidogrel 150 mg Tablet
Composition : Pantoprazole (40mg)
Composition : Pantoprazole (80mg) Dual Release Gastro-Resistant
Composition : Clopidogrel 75 mg Tablet
Composition : Clopidogrel 75mg + Aspirin 150mg Tablet
Composition : Astaxanthin (16mg) + Reduced Coenzyme Q10 (200mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Pioglitazone 15mg + Metformin Hydrochloride IP 500mg Tablet has strong demand in the diabetology, endocrinology, and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on anti-diabetic and lifestyle disease portfolios.
Medical distributors and agencies can benefit from the growing demand for Type 2 diabetes management under medical supervision. Pioglitazone 15mg is an insulin sensitizer that helps improve the body's response to insulin Metformin Hydrochloride IP 500mg is a widely prescribed anti-diabetic medication that helps reduce glucose production in the liver and improves insulin sensitivity This combination is commonly prescribed for the management of Type 2 Diabetes Mellitus in patients requiring combination therapy, as advised by healthcare professionals Helps achieve better glycemic control through complementary mechanisms of action Supports long-term diabetes management when combined with a healthy diet, exercise, and physician-directed treatment plans Oral tablet formulation provides convenient administration and promotes patient compliance Requires regular monitoring of blood glucose levels and overall treatment response Frequently utilized in diabetology clinics, endocrinology centers, hospitals, and general medicine practices Widely prescribed by diabetologists, endocrinologists, and general physicians This strengthens a comprehensive anti-diabetic and chronic care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Pioglitazone 15mg + Metformin Hydrochloride IP 500mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong prescription demand, long-term patient usage, repeat purchases, reliable supply chain support, and attractive margins in the anti-diabetic segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.